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Summary
Methionine restriction (MR) decreases body weight and adiposity
and improves glucose homeostasis in rodents. Similar to caloric
restriction, MR extends lifespan, but is accompanied by increased
food intake and energy expenditure. Most studies have exam-
ined MR in young animals; therefore, the aim of this study was to
investigate the ability of MR to reverse age-induced obesity and
insulin resistance in adult animals. Male C57BL/6J mice aged 2
and 12 months old were fed MR (0.172% methionine) or control
diet (0.86% methionine) for 8 weeks or 48 h. Food intake and
whole-body physiology were assessed and serum/tissues ana-
lyzed biochemically. Methionine restriction in 12-month-old mice
completely reversed age-induced alterations in body weight,
adiposity, physical activity, and glucose tolerance to the levels
measured in healthy 2-month-old control-fed mice. This was
despite a significant increase in food intake in 12-month-old MR-
fed mice. Methionine restriction decreased hepatic lipogenic
gene expression and caused a remodeling of lipid metabolism in
white adipose tissue, alongside increased insulin-induced phos-
phorylation of the insulin receptor (IR) and Akt in peripheral
tissues. Mice restricted of methionine exhibited increased circu-
lating and hepatic gene expression levels of FGF21, phosphory-
lation of eIF2a, and expression of ATF4, with a concomitant
decrease in IRE1a phosphorylation. Short-term 48-h MR treat-
ment increased hepatic FGF21 expression/secretion and insulin
signaling and improved whole-body glucose homeostasis with-
out affecting body weight. Our findings suggest that MR feeding
can reverse the negative effects of aging on body mass,
adiposity, and insulin resistance through an FGF21 mechanism.
These findings implicate MR dietary intervention as a viable
therapy for age-induced metabolic syndrome in adult humans.
Key words: activating transcription factor 4; aging; fibro-
blast growth factor 21; lipid; metabolism; unfolded protein
response.
Introduction
Aging is characterized by increased adiposity (Huffman & Barzilai, 2009)
and insulin resistance (Selman & Withers, 2011), which may play a role in
regulating lifespan (Huffman & Barzilai, 2009; Selman & Withers, 2011)
due to their association with further metabolic complications, including
type 2 diabetes, cardiovascular disease and cancer (Biddinger, 2006).
Removal of visceral fat is enough to increase mean and maximum
lifespan in rodents (Muzumdar et al., 2008). Visceral fat removal also
improves insulin sensitivity in rats (Barzilai et al., 1999) and enhanced
insulin sensitivity is a characteristic of many long-lived mouse models
(Selman & Withers, 2011).
Methionine restriction (MR) is a dietary technique, with the only
manipulation of the diet being a reduction in the essential amino acid
methionine (from 0.86% of the diet to 0.172%). Methionine restriction
has been shown previously to extend lifespan (Orentreich et al., 1993;
Richie et al., 1994), dramatically decrease body weight and adiposity,
and improve insulin sensitivity relative to animals on a control diet
(Hasek et al., 2010; Plaisance et al., 2010; Ables et al., 2012).
Methionine restriction has, therefore, been proposed to mimic effects
of caloric restriction (CR) (Masoro, 2005); however, in contrast to CR,
animals on MR diet are fed ad libitum and actually consume more food
than control-fed animals (Hasek et al., 2010; Plaisance et al., 2010).
This loss in body mass despite an increase in energy intake is thought to
be accomplished through creating a vast metabolic inefficiency, which
leads to increased energy expenditure, through uncoupling protein 1
(UCP1) nonshivering thermogenesis in adipose tissue (Hasek et al.,
2010). In young animals, MR stunts growth and development,
including reducing total length, serum insulin-like growth factor 1
(IGF-1), and growth hormone signaling (Ables et al., 2012). Fibroblast
growth factor (FGF) 21 is another regulator of growth that is released
from the liver in response to fasting through a PPARa mechanism
(Badman et al., 2007). FGF21 transgenic mice also show decreased
circulating levels of IGF-1 and are smaller than wild-type mice (Inagaki
et al., 2008).
Insulin responsiveness in tissues depends on insulin binding to the
insulin receptor (IR) on the surface of cells (Taniguchi et al., 2006). The
receptor autophosphorylates itself and, therefore, stimulates its own
tyrosine kinase activity, enabling it to phosphorylate and activate
downstream proteins, including the insulin receptor substrates (IRS)
and protein kinase B (PKB/Akt) to promote glucose uptake (Taniguchi
et al., 2006). Akt also stimulates the mechanistic target of rapamycin
complex 1 (mTORC1), which activates 4E binding protein 1 (4E-BP1) and
p70 ribosomal S6 kinase (p70S6K). p70S6K phosphorylates ribosomal
protein S6 (S6) to promote protein synthesis (Taniguchi et al., 2006). The
endoplasmic reticulum (ER) is responsible for protein folding and
maturation and in response to an overload of mis/unfolded proteins,
Correspondence
Dr. Mirela Delibegovic, Institute of Medical Sciences, School of Medical Sciences,
University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK. Tel.:
+44 1224 437587; fax: +44 1224 437465; e-mail: m.delibegovic@abdn.ac.uk
*Present address: Institute of Biodiversity, Animal Health and Comparative
Medicine, University of Glasgow, Graham Kerr Building, Glasgow, G12 8QQ, UK
Accepted for publication 18 May 2014
[Correction added on 9 September, after first publication: The References section
was updated to reflect the correct citation of articles in the list.]
ª 2014 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
817
Aging Cell (2014) 13, pp817–827 Doi: 10.1111/acel.12238
Ag
in
g 
Ce
ll
due to increased demands for protein synthesis, becomes overactivated/
stressed (Hotamisligil, 2010). In response to this stress, the unfolded
protein response (UPR) is induced (ER stress) and involves three signaling
branches, beginning with ER membrane-associated proteins; activating
transcription factor-6 (ATF6), inositol requiring enzyme 1 a (IRE1a), and
PKR-like endoplasmic reticulum kinase (PERK) (Hotamisligil, 2010).
Initiation of dietary MR early in life limits postweaning growth and
tissue deposition, but in most studies to date, regardless of duration, the
MR diet was provided continuously from a young age (Hasek et al., 2010;
Perrone et al., 2010). In contrast, the impact of initiating MR at different
ages in mice has not been systematically evaluated. As obese adults are
themain target forMR intervention in humans (Plaisance et al., 2011), we
aimed to examine the effectiveness of beginning MR at different ages,
including adult mice (2 and 12 months old), to investigate whether it can
reverse metabolic syndrome, and further identify whether it would make
a suitable therapy for adult insulin-resistant humans. In molecular
analyses, we focused on altered hepatic and white adipose tissue (WAT)
signaling pathways, as MR has been shown, through transcriptional
analysis, to exert its main action in these two tissues (Hasek et al., 2013).
Results
MR decreases body weight and fat mass, but increases food
intake, glucose tolerance, and levels of physical activity
To examine the effectiveness ofMRwhen beginning the diet straight after
weaning and when mice are fully grown and developed, the responses to
8 weeks of dietaryMRwere evaluated in C57BL/6J malemice in which the
diet was initiated at 2 and 12 months of age. There was a significant
increase in body weight from the 2-month- to the 12-month-old control-
fed mice (Fig. 1A). Methionine restriction was able to significantly reverse
this effect in the 12-month-old mice by decreasing body weight by 7.8 g
by week 5 of dietary treatment (Fig. 1A). Interestingly, by week 5, the
body weight of 12-month-old MR-fed mice reached a similar level to 2-
month-old control-fed mice (31.6 vs. 28.3 g, respectively) (Fig. 1A). The
control diet in the 12-month-old mice had little effect on body weight,
which stayed stable at a 0.3-g increase throughout the study (Fig. 1A). In
contrast, in young 2-month-old mice, the control diet produced a steady
increase in body weight throughout the study due to growth (1.8 g), but
MR prevented this and produced a significantly stable body weight loss,
losing 3.5 g by week 5 of dietary treatment (Fig. 1A).
Food intake was not different between the diets for 2-month-old mice
(Fig. 1B); however, the MR-fed mice weighed significantly less at every
week throughout the study (Fig. 1A); therefore, the bodyweight adjusted
food intake (g day1 per BW) for 2-month-old MR-fed animals was
significantly higher than 2-month-old control-fed mice (data not shown).
Young MR-fed animals (2 months) were able to sustain a smaller body
weight than control-fed animals by consuming the same amount of food
(Fig. 1A,B). In 12-month-old mice, food intake (g day1) was significantly
increased by MR (Fig. 1B), so MR-fed mice were able to maintain a lower
body weight with higher food consumption (Fig. 1A,B).
We examined the ability of MR to affect age-dependent changes in
biomarkers of metabolic health in 2- and 12-month-old mice. Diminished
glucose tolerance was present in 12-month- compared with 2-month-
old control-fed mice (Fig. 1C). Methionine restriction significantly
improved this effect on glucose excursion in 12-month-old mice and
reached the same level of blood glucose response, at all time points, as
healthy 2-month-old control-fed mice (Fig. 1C). Methionine restriction
also significantly enhanced glucose tolerance in 2-month-old mice
relative to their age-matched controls (Fig. 1C).
Lean mass (g) was significantly increased with age in control-fed mice
and decreased by MR diet (Fig. 1D), but this is merely a reflection of the
differences in total body weight (Fig. 1A), with % lean mass actually
significantly decreased in 12-month-old compared with 2-month-old
control-fed mice and significantly increased by MR relative to age-
matched controls (data not shown). Fat mass (total g and %)
significantly increased with age in control-fed mice (Fig. 1E,F). Methi-
onine restriction was able to reverse this effect in 12-month-old mice by
significantly decreasing fat mass to a comparable level of 2-month-old
control-fed mice (Fig. 1E,F). Furthermore, MR significantly reduced the
fat mass (g and %) of 2-month-old MR-fed mice relative to age-matched
control-fed mice (Fig. 1E,F).
We also examined the effect of MR diet on physical activity levels.
Physical activity levels significantly decreased with age in control-fed
mice (Fig. 1G). Within 12-month-old mice, MR significantly increased
activity levels, making the activity levels of 12-month-old MR-fed mice
(12.9 beam breaks min1) equivalent to that of 2-month-old control-fed
mice (13.2 beam breaks min1) (Fig. 1G).
MR improves glucose and lipid metabolism
Due to the substantial improvements in glucose tolerance by MR diet, we
went onto measure metabolic markers in the serum. Although MR
decreased fasting blood glucose levels in both age groups, this was only
significant in the 2-month-old mice (Fig. 2A). Aging had no effect on
fasting blood glucose levels but produced a significant rise in fasting
serum insulin levels (hyperinsulinemia) between 2- and 12-month-old
control-fed mice (Fig. 2B). Methionine restriction was able to decrease
fasting serum insulin levels significantly in 12-month-old mice, attaining
the level of 2-month-old control-fed mice (Fig. 2B). In 2-month-old mice,
fasting serum insulin levels were reduced by MR diet, but this was not
significant (Fig. 2B). Aging significantly increased serum leptin levels
between 2- and 12–month-old control-fed mice (Fig. 2C), but MR
lowered serum leptin levels by approximately threefold in both age
groups (Fig. 2C). Aging also increased fasting serum levels of free fatty
acids (FFAs) in control-fed mice (12 vs. 2 months old); however, diet
failed to alter FFAs at either age (Fig. 2D). Aging had no effect on serum
or hepatic triglyceride levels (Fig. 2E,F); however, MR significantly
decreased serum triglyceride levels in 2-month-old mice, but had no
effect in 12-month-old mice (Fig. 2E) and decreased hepatic triglycerides
in 12-month-old mice, but had no effect in 2-month-old mice (Fig. 2F).
MR increases lipogenic and oxidative gene expression in
epididymal WAT and decreases lipogenic gene expression in
liver
Diet-induced changes in circulating and tissue lipid levels suggest that
dietary MR may be modifying tissue-specific synthesis, export, uptake,
and/or oxidation of lipid. To explore these possibilities in greater detail,
changes in expression of genes involved in different aspects of lipid
metabolism were evaluated. In 12-month-old mice, MR had no effect on
the expression of lipogenic and adipogenic promoting genes; acetyl-coA
carboxylase 1 (ACC1) and sterol regulatory element-binding protein 1c
(SREBP1c) in epididymal WAT (Fig. 3A). However, MR significantly
upregulated acetyl-coA carboxylase 2 (ACC2) and stearoyl-CoA desat-
urase-1 (SCD1) (Fig. 3A). Dietary treatment had no effect in 12-month-
old mice on peroxisome proliferator-activated receptor gamma (PPARc),
fatty acid-binding protein 4 (FABP4), hormone-sensitive lipase (HSL), and
cluster of differentiation 36 (CD36) (Fig. 3A). Methionine restriction
significantly upregulated beta-3 adrenergic receptor (ADRB3) in
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12-month-old mice and in parallel with the decreased circulating leptin
levels, significantly decreased expression of leptin (Fig. 3A). Peroxisome
proliferator-activated receptor gamma coactivator 1-alpha (PGC-1a), a
master regulator of mitochondrial biogenesis, was increased significantly
by MR in WAT in 12-month-old mice, but peroxisome proliferator-
activated receptor alpha (PPARa) levels were unchanged (Fig. 3A). Levels
of mitochondrial transcription factor A (TFAM) were unchanged by MR,
but MR upregulated b-Klotho in 12-month-old mice; however, this was
not significant (Fig. 3A).
Methionine restriction produced similar changes to gene expression
levels in epididymal WAT in 2-month-old mice compared with the 12-
month-old mice (Fig. 3B). However, SCD1 was not changed by diet, but
FABP4 was significantly upregulated and PPARc was also increased
(P = 0.05) by MR (Fig. 3B). ADRB3 and leptin gene expression levels
were also not different between diets in 2-month-old mice, but TFAM
was significantly increased by MR (Fig. 3B).
In the liver, MR produced a significant downregulation of the lipogenic
genes, ACC2, SREBP1c, and SCD1 in 12-month-old mice (Fig. 3C).
Acetyl-coA carboxylase 1, fatty acid synthase (FAS), SREBP1a, glycerol-3-
phosphate dehydrogenase (GPD2), and carnitine palmitoyltransferase 1
A (CPT1A) mRNA expression levels were unaltered by diet in 12-month-
old mice (Fig. 3C). Conversely, MR significantly increased hepatic mRNA
expression of PPARc, CD36, and adipose triglyceride lipase (ATGL) in 12-
month-old mice (Fig. 3C), but expression levels of the gluconeogenic
genes; G6P and PEPCK were unaltered by diet (Fig. 3C). Methionine
restriction diet produced similar changes in hepatic gene expression in 2-
month-old mice (Fig. 3D), however, had no effect on ACC2 or PPARc
(Fig. 3D). These data indicate that MR induces gene expression altera-
tions that reduce hepatic lipid storage and promote fatty acid oxidation.
MR improves peripheral insulin signaling
Available evidence supports the view that MR increases metabolic
flexibility and overall in vivo insulin sensitivity (Hasek et al., 2010, 2013);
however, the effects of dietary MR on tissue-specific insulin sensitivity
have not been examined.
To assess insulin-dependent signaling, mice were injected with saline
or a physiological dose of insulin (0.8 mU g1) after a 5-h fast. The first
tissue examined was epididymal WAT. In 12-month-old mice, both
control and MR diet significantly increased levels of phosphorylation of
the IR from basal levels upon a bolus of insulin (Fig. 4A,B). In comparison
of diets, MR-fed mice had significantly higher levels of insulin-stimulated
phosphorylation of the IR than 12-month-old control-fed mice (Fig. 4A,
B). Basal phosphorylation of PKB/Akt was significantly reduced by MR
relative to control diet in 12-month-old mice (Fig. 4A,B), and MR diet
produced an increase from basal to insulin-stimulated levels of
phosphorylation of PKB/Akt (P = 0.08) (Fig. 4A,B). Insulin-stimulated
phosphorylation of S6 was significantly higher in MR diet compared with
control diet in 12-month-old mice, and MR significantly enhanced basal
to insulin-stimulated levels of phosphorylation of S6 (Fig. 4A,B).
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Fig. 1 Body weight, food intake, glucose
tolerance, lean mass, fat mass, and physical
activity levels of mice on methionine
restriction (MR) and control diet. (A) Body
weight measurements from the first
5 weeks of the study, (B) food intake from
a representative 4-week period of the
study, and (C) glucose tolerance as assessed
by a glucose tolerance test (dose of
glucose = 2 g kg1) after a 5-h fast in mice
fed MR or control diet at the ages of
2 months (n = 20) and 12 months
(n = 14). Significance was calculated by
repeated measures two-way ANOVA with
Bonferroni multiple comparison post hoc
tests. (D) Lean mass (g), (E) fat mass (g), and
(F) % fat mass of total body mass were
measured by dual-energy X-ray
absorptiometry in mice fed MR or control
diet at the ages of 2 months (n = 20) and
12 months (n = 14). Significance was
calculated by one-way ANOVA and Tukey’s
post hoc test. (G) Physical activity was
measured by beam breaks per minute in
mice fed MR or control diet at the ages of
2 months (n = 6) and 12 months (n = 6).
Significance was calculated by two-tailed
Student’s t-test. Data are represented as
mean  SEM. Black bars/circles, 12-month-
old control-fed mice; white bars/circles, 12-
month-old MR-fed mice; black hatch bars/
black triangles, 2-month-old control-fed
mice; white hatch bars/white triangles, 2-
month-old MR-fed mice. *MR-fed mice
significantly different to age-matched
control-fed mice (P < 0.05), #12-month-old
control-fed mice significantly different to 2-
month-old control-fed mice (P < 0.05).
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In 2-month-old mice, MR significantly increased levels of IR phos-
phorylation from basal to insulin stimulation and significantly enhanced
levels of insulin-stimulated IR phosphorylation relative to control diet (Fig.
S1A,B, Supporting information).
Next, hepatic insulin signaling was examined in the same way as
epididymal WAT in 12-month-old mice (Fig. 4C,D). There was no effect
of diet on phosphorylation levels of IR or PKB/Akt (Fig. 4C,D). Methi-
onine restriction diet in 12-month-old mice led to a significant increase in
phosphorylation of S6 from basal to insulin-stimulated conditions
(Fig. 4C,D). In 2-month-old mice, MR produced a significant increase
in levels of phosphorylation of Akt and S6 between basal and insulin-
stimulated conditions (Fig. S1C,D). In 2-month-old control-fed mice, this
only occurred with levels of phosphorylation of S6 (Fig. S1C,D).
Furthermore, insulin signaling was investigated in the gastrocnemius
muscle in 12-month-old mice (Fig. 4E,F). Levels of insulin-stimulated
phosphorylation of the IR were decreased by MR diet in comparison with
the control diet if corrected to total levels (Fig. 4E,F). However, it is
important to stress that there is an increase in total level of IR itself,
probably reflecting the fact that these mice are more insulin sensitive due
to decreased adiposity (Fig. 4E). There was no effect of diet on
phosphorylation levels of PKB/Akt (Fig. 4E,F). In 12-month-old mice,
MR significantly increased levels of phosphorylation of S6 from basal to
insulin stimulation (Fig. 4E,F). In 2-month-old mice, MR increased insulin-
stimulated levels of phosphorylation of Akt compared with control diet,
and MR also significantly enhanced basal to insulin-stimulated levels of
phosphorylation of Akt and S6 (Fig. S1E,F).
MR increases serum and hepatic gene expression of FGF21
and associated targets
FGF21 improves hepatic steatosis and insulin sensitivity in obese mice by
stimulating lipolysis and fatty acid oxidation and reducing gluconeogen-
esis (Xu et al., 2009a). Methionine restriction increased levels of serum
FGF21 by 2.5-fold in 12-month-old mice (Fig. 5A) and significantly
increased hepatic gene expression of FGF21 (Fig. 5B).
FGF21 induction in the liver is linked to the SIRT1-PGC-1a-PPARa
pathway (Purushotham et al., 2009), and we found SIRT1 to be
significantly increased by MR in 12-month-old mice; however, PGC1a
and PPARa were unchanged (Fig. 5B). FGF21 suppresses the GH/IGF-1
signaling axis in liver (Zhang et al., 2012); however, MR had no effect
on IGF-1 expression in 12-month-old mice, but, SOCS2, an inhibitor
of the GH-signaling cascade, was significantly increased by MR
(Fig. 5B).
In 2-month-old mice, MR significantly increased serum levels of FGF21
and hepatic expression of FGF21 and PGC1a, but had no effect on SIRT1,
PPARa, IGF-1, or SOCS2 mRNA expression (Fig. 5C,D).
MR increases hepatic eIF2a phosphorylation and ATF4 gene
expression
Amino acid limitation has been shown to activate the PERK arm of ER
stress signaling via eukaryotic translation initiation factor 2a (eIF2a)
phosphorylation and induction of activating transcription factor 4 (ATF4)
(Harding et al., 2003); therefore, we went on to examine these markers
in the liver.
Methionine restriction significantly upregulated mRNA expression of
ATF4 (Fig. 5B) and significantly increased levels of phosphorylation of
eIF2a (Fig. 5E,G) in 12-month-old mice. To ensure it was not an
induction of the entire UPR, we examined the first component of
another of the UPR branches; IRE1a. Methionine restriction significantly
decreased insulin-stimulated IRE1a phosphorylation in 12-month-old
mice (Fig. 5E,G).
In 2-month-old mice MR significantly increased ATF4 mRNA expres-
sion (Fig. 5D) and levels of eIF2a phosphorylation (Fig. 5F,H); however,
dietary treatment had no effect on levels of phosphorylation of IRE1a
(Fig. 5F,H).
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Fig. 3 Epididymal white adipose tissue
(WAT) and hepatic gene expression in mice
on methionine restriction (MR) and control
diet. Gene expression was measured by
qPCR in (A) epididymal WAT in 12-month-
old mice (n = 5–6), (B) epididymal WAT in
2-month-old mice (n = 4–6), (C) liver in 12-
month-old mice (n = 5–8) and (D) liver in 2-
month-old mice (n = 4–6) fed MR or
control diet. Data were analyzed as fold
change relative to control-fed mice.
Significance was calculated between MR
and control diet by two-tailed Student’s t-
test (*P < 0.05). Data are represented as
mean  SEM. Black bars, 12-month-old
control-fed mice; white bars, 12-month-old
MR-fed mice; black hatch bars, 2-month-
old control-fed mice; white hatch bars, 2-
month-old MR-fed mice.
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MR increases FGF21 levels and improves glucose tolerance
after 48 h of treatment
To examine metabolic effects of MR before the effects on body weight,
mice were fed MR or control diet for 48 h. After 48 h, there was no
change in body weight (Fig. 6A), but serum levels of FGF21 were
significantly increased by over sevenfold (Fig. 6B) and hepatic gene
expression of FGF21 was significantly increased by over 12-fold by
dietary MR (Fig. 6C). Methionine restriction improved glucose tolerance
after just 48 h, as assessed in a glucose tolerance test (GTT), with a
significant decrease in blood glucose levels at 30 min postinjection
(Fig. 6D). Furthermore, after 48 h, MR induced a significant increase in
phosphorylation of the IR and S6 from basal to insulin-stimulated levels
in the liver (Fig. 6E,F), whereas both MR and control diet increased levels
of phosphorylation of PKB/Akt from basal to insulin stimulation (Fig. 6E,
F). Therefore, MR is able to induce hepatic FGF21 expression and insulin
sensitivity and improve whole-body glucose homeostasis, prior to any
changes in body weight.
Discussion
Aging causes fat accumulation (Huffman & Barzilai, 2009) and dampens
insulin sensitivity and whole-body glucose homeostasis (Selman &
Withers, 2011), as apparent in this study in the differences we observed
between 2- and 12-month-old control-fed mice. We found aging to lead
to increased body weight and adiposity and diminished glucose
tolerance and insulin sensitivity, associated with increased fasting serum
insulin and leptin levels.
Dietary manipulation in the form of MR has been shown before to
dramatically decrease body weight and adiposity and improve insulin
sensitivity in young, healthy mice (Hasek et al., 2010, 2013; Perrone
et al., 2010; Plaisance et al., 2010). We have shown here for the first
time that MR is able to reverse aging-associated alterations in
physiology, specifically to decrease body fat, increase physical activity,
and improve glucose and lipid homeostasis to the levels measured in
young mice (fed a normal diet). The increase in age-related adiposity
is linked to enhanced risk of diseases and reduced lifespan (Huffman
& Barzilai, 2009). Therefore, the ability of MR to reverse age-induced
insulin resistance and dysfunctional lipid metabolism, back to levels
of healthy young mice, may play a role in its ability to extend
lifespan.
This study strengthens the translational evidence for MR as an
effective intervention feasible in humans, and treatments that are not
only capable of preventing but also treating metabolic dysfunction in
adults are urgently needed, due to the rising prevalence of metabolic
syndrome (Ford et al., 2004). The fact that MR allows greater food
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consumption, while simultaneously decreasing body weight and adipos-
ity, makes it a more sustainable option than dietary restriction.
Methionine restriction produced similar beneficial metabolic effects
when begun at 12 months compared with 2 months of age, suggesting
that initiating MR at an early age may not be necessary for positive
effects on longevity.
In 12-month-old mice, MR was able to produce an increase in
lipogenic and oxidative gene expression in epididymal WAT and decrease
in lipogenic but increase in lipolytic gene expression in the liver,
consistent with lipid homeostasis remodeling shown previously by MR in
young mice (Perrone et al., 2010; Hasek et al., 2013). These changes are
likely to account for the decrease in serum and hepatic triglycerides
produced by MR, consistent with earlier studies (Ables et al., 2012;
Hasek et al., 2013).
Improvements in whole-body glucose homeostasis with MR have
been shown before, but tissue-specific insulin sensitivity at the protein
level has not been examined. The major effects of MR on insulin
signaling occurred in epididymal WAT; however, hepatic and muscle
insulin signaling also showed moderate improvements. Within compo-
nents of the insulin signaling pathway, the significant increase from basal
to insulin-stimulated levels of phosphorylation, produced by MR,
expresses an enhanced ability of peripheral tissues to respond to a
bolus of insulin. These findings support those from previous studies,
which found MR to increase metabolic flexibility, shown through an
enhanced range of respiratory quotient from day to night (Hasek et al.,
2010).
Previous results have also found MR to increase circulating (Ables
et al., 2012) and hepatic gene expression of FGF21 (Ables et al., 2012;
Perrone et al., 2012) and one of its target genes, PGC1a (Perrone et al.,
2010). Although FGF21 could be induced by a PPARa mechanism
(Badman et al., 2007), due to upregulation of SIRT1 and PGC1a, PPARa
was unchanged. An alternative is that FGF21 is induced in the liver under
leucine deprivation through the general control nonderepressible 2
(GCN2) – phospho-eIF2a – ATF4 pathway (De Sousa-Coelho et al.,
2012). Dietary MR resulted in enhanced levels of phosphorylation of
eIF2a and substantial upregulation of hepatic ATF4 mRNA expression,
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suggesting activation of GCN2. In addition, the reduction in levels of
phosphorylation of IRE1a in 12-month-old mice ensures that the
induction of eIF2a was not representative of activation of the entire
UPR and that it was only this specific branch that responds to amino acid
deficiency (De Sousa-Coelho et al., 2012). Moreover, it provides
evidence that MR can reduce specific aspects of ER stress while
increasing the plausibility that FGF21 is induced in the same way in
response to MR as it is upon leucine deprivation.
FGF21 upregulation after just 48 h of MR feeding preceded any
change in body weight, suggesting that FGF21 could be responsible for
the effects of MR on body weight and adiposity. Indeed, FGF21 has
dramatic effects to reverse obesity in high-fat diet-induced obese mice
(Xu et al., 2009a). The improvements in whole-body glucose homeo-
stasis could conceivably be secondary to MR decreasing adiposity and
body weight; however, after 48 h of MR feeding, glucose tolerance and
hepatic insulin sensitivity were also improved. This provides supporting
evidence for MR’s effects on insulin sensitivity not being entirely
secondary to body weight loss and there being another contributing
factor. The improvement was in line with FGF21 induction, and FGF21
has been shown to have insulin-sensitizing effects independently of body
weight alterations, including significantly enhanced hepatic and periph-
eral insulin sensitivity and restored glucose tolerance in diet-induced
obese mice (Xu et al., 2009a).
FGF21 could play a role in the metabolic effects of MR in the liver,
where decreased lipogenic gene expression and lipid storage was
present in MR-fed animals. FGF21 induction in the liver in response to
leucine deprivation caused downregulation of hepatic lipogenesis and
reduced hepatic lipid accumulation, the effects of which were absent
when FGF21 KO mice were deprived of leucine (De Sousa-Coelho et al.,
2012). Moreover, FGF21 reduces GH/IGF-1 signaling (Zhang et al.,
2012); therefore, the upregulation of hepatic SOCS2 expression could
also be produced by FGF21.
Adipose tissue is sensitive to circulating FGF21 as it contains high
levels of the essential coreceptor, b-Klotho (Fisher et al., 2011), which
was upregulated by MR. FGF21 in adipose tissue plays a role in
thermogenesis and browning of WAT, through activation of UCP1 and
PGC1a (Fisher et al., 2012), and could explain the upregulation of
oxidative gene expression, PGC1a and TFAM, in response to MR in
epididymal WAT and earlier findings of MR increasing energy expendi-
ture and WAT UCP1 levels (Hasek et al., 2010).
CON
MR
0 1 2
30
35
40
45
Days on diet
B
od
y 
w
ei
gh
t (
g)
0
1000
2000
3000
4000
5000 *
Se
ru
m
 F
G
F2
1 
(p
g 
m
l–1
)
0
5
10
15
20
*
FG
F2
1 
(r
el
at
iv
e 
ge
ne
 e
xp
re
ss
io
n)
0 60 120
0
5
10
15
20
25
30
35
15 30
*
*
*
Time (min)
B
lo
od
 g
lu
co
se
 (m
M
)
pIR
pAkt
pS6
Akt
S6
IR-β
CON MR
Saline Insulin InsulinSaline
2 DAY LIVER
pIR pAkt pS6
0.0
0.5
1.0
1.5
2.0
* *
*
*
Fo
ld
 c
ha
ng
e
CON saline
CON insulin
MR saline
MR insulin
CON
MR
CON
MR
(A)
(E) (F)
(B) (C) (D)
Fig. 6 Effects of 48-h methionine restriction (MR) treatment on body weight, FGF21 and glucose homeostasis. (A) Body weight in mice fed MR or control diet (n = 13).
Significance was calculated by repeated measures two-way ANOVA with Bonferroni multiple comparison post hoc tests (*P < 0.05). (B) Serum FGF21 (n = 13) and (C)
hepatic gene expression of FGF21 (n = 6) in mice fed MR or control diet. Data for gene expression were analyzed as fold change relative to control-fed mice. Significance
was calculated by two-tailed Student’s t-test (*P < 0.05). (D) Glucose tolerance as assessed by a glucose tolerance test (dose of glucose = 2 g kg1) after a 5-h fast in mice
fed MR or control diet (n = 9–10). Significance was calculated by repeated measures two-way ANOVA with Bonferroni multiple comparison post hoc tests (*P < 0.05). Black
bars/circles, control-fed mice; white bars/circles, MR-fed mice. Insulin signaling was assessed by administering either a saline (n = 3) or high dose of insulin (10 mU g1)
(n = 5–6) to mice, via i.p. injection, after a 5 h fast. (E) Levels of phosphorylated IR (tyr 1162/1163), protein kinase B/Akt (ser473), S6 (ser235/236), IR-b, total Akt, and total
S6 were measured by immunoblotting in liver in mice fed MR or control diet. (F) Immunoblots were normalized to Ponceau S and total protein in liver in mice fed MR or
control diet. Data were analyzed as fold change relative to control-fed insulin-injected mice. Significance was calculated by two-tailed Student’s t-test (*P < 0.05). Data are
represented as mean  SEM. Black hatch bars, control-fed mice injected with saline; black bars, control-fed mice injected with insulin; white crossed bars, MR-fed mice
injected with saline; white bars, MR-fed mice injected with insulin.
Methionine restriction reverses metabolic aging, E. K. Lees et al.824
ª 2014 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Interestingly, FGF21 also produces a lipid futile cycle in WAT (Coskun
et al., 2008), which agrees with the results of this study and others,
where MR produced a simultaneous increase in lipogenic and oxidative
gene expression in epididymal WAT (Perrone et al., 2008, 2010, 2012;
Hasek et al., 2013). FGF21 also increases glucose uptake into WAT (Xu
et al., 2009b), which could explain the effects of MR to significantly
increase insulin-stimulated phosphorylation of the IR and S6 compared
with control diet. In addition, FGF21 has been shown to cause
hyperphagia (Coskun et al., 2008), which could explain the increased
food intake by MR-fed animals.
In conclusion, we present the data that MR is able to reverse age-
induced metabolic dysfunction in fully developed adult mice, back to
levels of young, healthy mice on a normal diet. This could explain the
increased lifespan of mice when MR diet was begun at 12 months of
age (Sun et al., 2009). In addition, like MR, FGF21 treatment extends
lifespan in mice (Zhang et al., 2012) and FGF21 could be the basis of the
mechanism behind MR’s effects to reverse age-induced dysfunctional
metabolism, through the remodeling of hepatic and WAT lipid homeo-
stasis. This study also provides evidence that the effects of MR are not
only secondary to its effects on reducing growth and development and
that in fully developed and grown mice, it may slow aging.
Experimental procedures
Animals
This study was approved by the University of Aberdeen Ethics Review
Board and performed under UK Home Office project license PPL 60/
3951. Male C57BL/6J wild-type mice (Charles River, Edinburgh, UK) were
singly housed. Mice were exposed to 12-h light/dark cycle at 22–24 °C
and had ad libitum access to food and water. Mice were placed on a
control diet containing 0.86% methionine (Dyets, Bethlehem, PA, USA)
for 2 weeks. Within each age category, mice were randomized by body
weight; half were maintained on control diet and half were switched to
MR diet containing 0.172% methionine (Dyets). The glutamic acid
content of the MR diet was increased to compensate for the reduced
methionine content and to create equal amounts of total amino acids in
both diets. Mice were maintained on diets for 8 weeks (or 48 h where
indicated) and terminal tissues collected after a 5-h fast plus intraperi-
toneal (i.p.) injection with saline (154 mM NaCl) or a low, physiological
dose of insulin (0.8 mU g1 body weight) and sacrificed after 10 min.
Tissues were immediately dissected and frozen in liquid nitrogen after
cervical dislocation. In the short-term study, mice were maintained on
MR and control diets for 48 h and terminal tissues collected in the same
way, with the only difference being in the dosage of insulin (10 mU g1
body weight).
Whole-body measurements and blood metabolites
Body weight and food intake were measured every 3 days throughout
the study. Body composition was measured after 28 days on MR or
control diet by dual-energy X-ray absorptiometry (DEXA) (Lunar
PIXIMUS-Densitometer; GE Medical Systems, San Francisco, CA, USA).
GTTs were performed after 32 days on MR or control diet and involved
fasting for 5 h prior to i.p. injection with glucose (2 g kg1 body weight).
Tail blood glucose measurements using glucometers (AlphaTRAK,
Berkshire, UK) were taken immediately before and 15, 30, 60, and
120 min after i.p. injection with glucose. Tail vein blood samples were
taken after a 5 h fast, after 39 days on MR or control diet. All serum
measurements were taken on these. Serum leptin (Crystal Chem,
Downers Grove, IL, USA), insulin (Crystal Chem), and FGF21 (Millipore,
Darmstadt, Germany) were determined by ELISA. Serum glucose was
measured by glucose oxidase assay (Thermo Scientific, Waltham, MA,
USA). Serum triacylglycerol (17628; Sentinel Diagnostics, Milan, Italy)
and serum FFAs (Wako Chemicals, Richmond, VA, USA) were deter-
mined using appropriate kits. In the short-term study, tail vein blood
samples were taken after mice were sacrificed and these were used to
measure FGF21 by ELISA. Another cohort of male C57BL/6J wild-type
mice was used to measure glucose tolerance, in the same way as
described above, after 48 h of dietary treatment.
Locomotor activity measurement
Daily locomotor activity was monitored after 45 days on MR or control
diet, using passive infrared sensors (Panasonic – AMN11112; Farnell,
Leeds, UK) mounted on top of each cage. Clocklab software (Actimet-
rics, Wilmette, IL, USA) was used to acquire and analyze data generated
by the PIR sensors. Animals were given 48 h to acclimatize to the
presence of the PIR sensor, before data were recorded from each
individual animal every minute for seven consecutive days under 12-h
light/dark cycles. Data were expressed as beam breaks per minute and
consolidated into 1 h bins for analysis.
Liver triacylglycerols
Liver pieces (100 mg) were cut and weighed. Each sample was
homogenized in 1 mL PBS before being centrifuged for 15 s at room
temperature. The top layer was resuspended, and the supernatant
fraction was assayed for triacylglycerols using a commercial kit (Sentinel
Diagnostics).
Immunoblotting
Frozen liver and epididymal WAT lysates were prepared in RIPA buffer, as
described previously (Delibegovic et al., 2007). Proteins were separated
by 4–12% SDS-PAGE and transferred to nitrocellulose membranes.
Immunoblots were performed using antibodies from Cell Signaling
Technology (Cell Signaling by NEB, Hitchin, UK) (unless stated otherwise)
against phospho-S6 (s235/236) 4858S; total S6 2217S; phospho-Akt/
PKB (s473) 9271S; phospho-eIF2a (s51) 9721S; total eIF2a 5324S; total
IRE1a 3294S; phospho-IRE1a (s724) PA1-16927 (Thermo Scientific);
phospho-IR (tyr1163/1163) 44804G (Invitrogen, Paisley, UK); phospho-IR
(tyr1158) 44802G (Invitrogen); IR-b sc-711 (Santa Cruz, Dallas, TX, USA);
total Akt/PKB A2210 (Santa Cruz); and extracellular signal-regulated
kinase 2 (ERK2) I2908 (Santa Cruz). Proteins were visualized with
enhanced chemiluminescence and quantified using Bio-1D software
(Peqlab, Sarisbury Green, UK).
Gene expression in liver and epididymal WAT
Total RNA was isolated from frozen liver and epididymal WAT using
peqGOLD TriFast (Peqlab). For epididymal WAT, homogenates were
centrifuged and had the lipid layer removed before phase separation.
cDNA was synthesized from 1 lg RNA using bioscript cDNA synthesis
kit (Bioline, London, UK), oligo (dT) 18 primers and random hexamer
primers. Target genes were amplified by quantitative PCR (qPCR),
using gene-specific primers and GoTaq qPCR master mix (Promega,
Southampton, UK) on the LightCycler-480 (Roche, Burgess Hill, UK).
Relative mRNA levels were calculated using the Pfaffl method (Pfaffl,
2001) and normalized to a geometric mean of three reference genes;
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beta-actin, hypoxanthine-guanine phosphoribosyltransferase (HPRT),
and Ywhaz for the liver, and Nono, Ywhaz, and HPRT for epididymal
WAT.
Statistical analysis
Data are expressed as mean  SEM. Statistical analyses were performed
using repeated measures two-way ANOVA with Bonferroni multiple
comparison post hoc tests, one-way ANOVA with Tukey’s post hoc test,
or two-tailed Student’s t-tests, as appropriate. GRAPHPAD PRISM 5 software
(GraphPad Software, Inc., San Diego, CA, USA) was used for analyses. P-
values < 0.05 were considered significant.
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Fig. S1 Peripheral insulin signaling in 2-month-old mice on MR and control
diet.
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